New insider activity at Insulet ( (PODD) ) has taken place on February 26, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Insulet director Michael Minogue has signaled confidence in the company by purchasing 2,030 shares of Insulet stock in a recent transaction. The total value of this insider buy amounts to $499,846, underscoring a significant personal investment in the company’s future prospects.
Recent Updates on PODD stock
Insulet shares reacted to a strong Q4 beat and upbeat call that emphasized robust double‑digit Omnipod growth, expanding margins, and cash generation, but also guided to slower 2026 revenue growth due to tough comps, higher capex, and rising interest expense. Multiple firms trimmed price targets mainly to reflect this more tempered forward outlook and updated long‑term models, even as they cited sustained demand, early type 2 adoption, and international expansion as support for Insulet’s competitive position.
Spark’s Take on PODD Stock
According to Spark, TipRanks’ AI Analyst, PODD is a Neutral.
The score is driven primarily by strong financial performance (high growth, strong margins, improved balance sheet, and positive free cash flow) and supportive earnings-call guidance/margin expansion plans. These positives are meaningfully tempered by weak technicals (downtrend with negative MACD) and a high P/E with no dividend support, which increases sensitivity to any execution or growth slowdowns.
To see Spark’s full report on PODD stock, click here.
More about Insulet
YTD Price Performance: -12.71%
Average Trading Volume: 888,957
Technical Sentiment Signal: Sell
Current Market Cap: $17.26B